- Home
- AVTX vs EURK Comparison
AVTX vs EURK Comparison
Compare AVTX & EURK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- EURK
- Stock Information
- Founded
- AVTX 2011
- EURK 2023
- Country
- AVTX United States
- EURK Hong Kong
- Employees
- AVTX N/A
- EURK N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- EURK
- Sector
- AVTX Health Care
- EURK
- Exchange
- AVTX Nasdaq
- EURK NYSE
- Market Cap
- AVTX 88.4M
- EURK 80.0M
- IPO Year
- AVTX 2015
- EURK 2024
- Fundamental
- Price
- AVTX $7.42
- EURK $10.27
- Analyst Decision
- AVTX Strong Buy
- EURK
- Analyst Count
- AVTX 5
- EURK 0
- Target Price
- AVTX $36.75
- EURK N/A
- AVG Volume (30 Days)
- AVTX 102.5K
- EURK 18.4K
- Earning Date
- AVTX 05-12-2025
- EURK 01-01-0001
- Dividend Yield
- AVTX N/A
- EURK N/A
- EPS Growth
- AVTX N/A
- EURK N/A
- EPS
- AVTX N/A
- EURK N/A
- Revenue
- AVTX $820,000.00
- EURK N/A
- Revenue This Year
- AVTX N/A
- EURK N/A
- Revenue Next Year
- AVTX N/A
- EURK N/A
- P/E Ratio
- AVTX N/A
- EURK N/A
- Revenue Growth
- AVTX N/A
- EURK N/A
- 52 Week Low
- AVTX $4.35
- EURK $10.03
- 52 Week High
- AVTX $34.46
- EURK $10.27
- Technical
- Relative Strength Index (RSI)
- AVTX 49.36
- EURK N/A
- Support Level
- AVTX $6.38
- EURK N/A
- Resistance Level
- AVTX $8.40
- EURK N/A
- Average True Range (ATR)
- AVTX 1.11
- EURK 0.00
- MACD
- AVTX 0.08
- EURK 0.00
- Stochastic Oscillator
- AVTX 21.93
- EURK 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.